hTERT-targeted T-cell therapy (Takara Bio/Green Cross)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamehTERT-targeted T-cell therapy (Takara Bio/Green Cross)
Drug Alias Nameactivated T-lymphocyte immunotherapy (Takara Bio/Green Cross)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionTelomerase modulators
TargetsTelomerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakara Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGC Biopharma CorpTakara Bio Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A